Suppr超能文献

阿尔茨海默病患者大脑中高分子量激肽原的积累可能通过改变吞噬作用和溶酶体组织蛋白酶活性来影响小胶质细胞功能。

Accumulation of high molecular weight kininogen in the brains of Alzheimer's disease patients may affect microglial function by altering phagocytosis and lysosomal cathepsin activity.

机构信息

Regeneron Pharmaceuticals, Tarrytown, New York, USA.

出版信息

Alzheimers Dement. 2022 Oct;18(10):1919-1929. doi: 10.1002/alz.12531. Epub 2022 Jan 3.

Abstract

Increased activation of the contact system protein high molecular weight kininogen (HK) has been shown in plasma and cerebrospinal fluid of Alzheimer's disease (AD) patients, but its potential role in the brain has not been explored. We assessed HK levels in brain tissue from 20 AD patients and controls and modeled the effects of HK on microglia-like cells in culture. We show increased levels of HK in the hippocampus of AD patients, which colocalized with amyloid beta (Aβ) deposits and activated microglia. Treatment of microglia with HK led to cell clustering and elevated levels of phagocytosed Aβ. We demonstrate that microglia internalize HK and traffic it to lysosomes, which is accompanied by reduced activity of lysosomal cathepsins L and S. Our results suggest that HK accumulation in the AD hippocampus may alter microglial uptake and degradation of Aβ fibrils, possibly contributing to microglial dysfunction in AD.

摘要

已在阿尔茨海默病(AD)患者的血浆和脑脊液中发现接触系统蛋白高分子量激肽原(HK)的活性增加,但其在大脑中的潜在作用尚未得到探索。我们评估了 20 名 AD 患者和对照组脑组织中的 HK 水平,并在培养的类小胶质细胞中模拟了 HK 的作用。我们发现 AD 患者海马体中的 HK 水平升高,与淀粉样蛋白β(Aβ)沉积和激活的小胶质细胞共定位。用 HK 处理小胶质细胞会导致细胞聚集和吞噬的 Aβ水平升高。我们证明小胶质细胞内化 HK 并将其转运到溶酶体,这伴随着溶酶体组织蛋白酶 L 和 S 的活性降低。我们的结果表明,AD 海马体中 HK 的积累可能改变小胶质细胞对 Aβ纤维的摄取和降解,可能导致 AD 中小胶质细胞功能障碍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验